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Abstract
Background:  Rapid and accurate diagnosis of tuberculosis (TB) is crucial to facilitate early
treatment of infectious cases and thus to reduce its spread. To improve the diagnosis of TB, more
rapid diagnostic techniques such as antibody detection methods including enzyme-linked
immunosorbent assay (ELISA)-based serological tests and immunochromatographic methods were
developed. This study was designed to evaluate the validity of an immunochromatographic assay,
ICT Tuberculosis test for the serologic diagnosis of TB in Antalya, Turkey.
Methods: Sera from 72 patients with active pulmonary (53 smear-positive and 19 smear-negative
cases) and eight extrapulmonary (6 smear-positive and 2 smear-negative cases) TB, and 54 controls
from different outpatient clinics with similar demographic characteristics as patients were tested
by ICT Tuberculosis test.
Results: The sensitivity, specificity, and negative predictive value of the ICT Tuberculosis test for
pulmonary TB were 33.3%, 100%, and 52.9%, respectively. Smear-positive pulmonary TB patients
showed a higher positivity rate for antibodies than smear-negative patients, but the difference was
not statistically significant. Of the eight patients with extrapulmonary TB, antibody was detected in
four patients.
Conclusion: Our results suggest that ICT Tuberculosis test can be used to aid TB diagnosis in
smear-positive patients until the culture results are available.
Background
A curable and preventable disease, tuberculosis (TB) con-
tinues to be a leading cause of mortality and morbidity
worldwide. Early treatment of infectious cases reduces
spread of TB. Therefore rapid and accurate identification
of infected individuals is mandatory [1,2].
Currently, mycobacteriology laboratory algorithm to
detect Mycobacterium tuberculosis (M. tuberculosis) consists
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of two steps: microscopic examination of a smear pre-
pared from a concentrated specimen (sputum, bronchoal-
veolar lavage fluid, aspirates, etc) and culture. Smear
microscopy allows direct detection of acid fast bacilli
(AFB) in the specimen and identification of the most con-
tagious patients. Although smear microscopy provides
rapid results and inexpensive ways to diagnose TB, it has
limitations. Probably the most important limitation is
low sensitivity. Behr et al. reported that smear examina-
tion can detect less than 50% of all culture positive
patients [3]. Culture, on the other hand, is more effective
than smear microscopy. While 104 AFB/ml of specimen
usually result in 60% of smear positivity, only ten viable
bacilli per milliliter are required for culture positivity. The
sensitivity of culture is 80%–85%. Additionally, identifi-
cation and susceptibility testing of the isolates are major
advantages of the cultural methods except that they take
relatively long growth time. Today, TB diagnosis in
resource limited countries mostly depends on clinical and
radiological findings, as well as sputum smear microscopy
and culture [4,5].
In response to the need for a rapid diagnosis of TB, a
number of new approaches and methods were developed
for the serological diagnosis. There are several serological
tests, which use various native or recombinant antigens
such as 38-kDa antigen, lypoarabinomannan, antigen 60
(A60), and tuberculous glycolipids (TBGL's). These
include several enzyme-linked immunosorbent assay
(ELISA)-based serological tests and immunochromato-
graphic methods to detect antibodies to M. tuberculosis [6-
10].
According to WHO Report 2002 on Global Tuberculosis
Control, Turkey was classified in Category 1, which
includes countries not implementing the DOTS strategy
and having an estimated incidence rate of 10 or more
cases per 100 000 population. In this report, a number of
18 038 of diagnosed cases and an incidence rate of 27 per
100 000 population of TB for Turkey were reported [11].
However this data do not reflect the true incidence of TB
in Turkey due to underreporting and undiagnosed cases
[12].
In this study, we evaluated an immunochromatographic
assay, ICT Tuberculosis test which detects serum antibod-
ies against five antigens that are secreted by M. tuberculosis
during active infection by determining its sensitivity and
specificity as compared to standard diagnostic procedures
in a university hospital setting in Turkey.
Methods
Patients
Between April 1999 and December 2000, 80 patients with
active TB were evaluated. All were human immunodefi-
ciency virus negative. There were 15 female (18.75%) and
65 males (81.25%) aged between 14 to 76 years (median
39 years). Of the 80 patients with active TB, 72 (90%) had
pulmonary disease and eight (10%) had extrapulmonary
disease. Among patients with pulmonary disease, 53
(73.6%) patients were both smear and culture positive, 19
(26.4%) patients were smear-negative and culture-posi-
tive. Extrapulmonary disease included pleural disease
(three patients), lymphadenitis (four patients), and epidi-
dymitis (one patient). Of the eight patients with extrapul-
monary disease, two were both smear and culture
positive, six patients were only culture-positive.
Control group
The control group consisted of 54 individuals selected
randomly from individuals who applied to different out-
patient chest clinics for employment TB screening. All
members of control group had no previous history of TB,
no signs or symptoms suggestive of pulmonary TB, no evi-
dence of TB on chest X rays.
The 54 subjects selected for the control group had a
median age of 41 years (age range, 18–75 years) and 43
(79.6%) were males, 11 (20.4%) were females. All were
HIV negative. Demographic characteristics of patients and
control subjects were similar.
Serum samples were obtained from almost all patients
before initiation of antituberculosis treatment and stored
at -80°C until tested. All patients and controls partici-
pated in the study were vaccinated with Mycobacterium
bovis BCG.
Akdeniz University Medical Faculty Ethical Committee
approved this study.
Microbiological analysis
Routine TB examination included demonstration of AFB
in Ziehl-Neelsen stained smears from sputum, bronchoal-
veolar lavage (BAL) fluid, aspirates or tissue biopsy sam-
ples, and culture according to standard procedures [5].
ICT Tuberculosis test
The ICT Tuberculosis diagnostic kit (ICT Diagnostics, Ban-
gowlah, New South Wales, Australia) is designed for the
detection of antibodies to M. tuberculosis. Briefly, five
highly purified antigens (including one of 38 kDa)
secreted by M. tuberculosis during active infection are
immobilized in four lines on the test strip. When serum or
plasma applied, it flows past the antigen line. Bound anti-
body is detected by a goat anti-human IgG antibody con-
jugated to colloidal gold particles which produces one or
more pink lines when bound to human antibody. The
whole procedure is completed within 20 minutes. ICTBMC Infectious Diseases 2006, 6:37 http://www.biomedcentral.com/1471-2334/6/37
Page 3 of 4
(page number not for citation purposes)
Tuberculosis test doesn't require special equipment and
technical skill.
Statistical analysis
Validity of ICT Tuberculosis test was measured by sensitiv-
ity and specificity. Negative predicitive value was also cal-
culated. Antibody positivity rates between smear-positive
and smear-negative patients were compared by chi-square
test.
Results
Antibody was detected in 21 of 53 (29.2%) smear and cul-
ture-positive patients, three of 19 (4.2%) smear-negative
culture-positive patients. Patients with smear positivity
showed a higher positivity rate for antibodies than smear-
negative patients but the difference was not statistically
significant (χ2: 3.57, p: 0.058). We found the sensitivity
33.3% and specificity 100% with a negative predictive
value of 52.9% for pulmonary TB.
Of the eight patients with culture-proven extrapulmonary
TB, antibody was detected in four patients. Sensitivity of
the test for the extrapulmonary TB patients was not calcu-
lated because of the small number of the patients. None
of the control subjects tested positive by the ICT Tubercu-
losis test.
Discussion
Serologic tests are the oldest methods for the diagnosis of
TB. Agglutination of patient's serum with M. tuberculosis
was investigated first in 1898 [13]. Since then, a number
of serologic tests were developed for detection of host
response to M. tuberculosis, but none of them has found
widespread clinical use. The specificity of the early sero-
logical tests which were prepared from crude antigens
were low because of cross reaction with environmental
Mycobacterium species. Specificity could be improved by
using purified antigens. A variety of antigens have been
adapted for the serodiagnosis of TB. Certain antigens were
found to have more diagnostic significance, one of them,
38 kDa antigen which is a phosphate-binding protein,
was reported to be specific to the M. tuberculosis complex.
This antigen has been identified as a potential reagent to
be used for the screening of TB [5].
Cole et al. [14] evaluated a rapid membran-based anti-
body assay which contained only the 38 kDa antigen, for
the diagnosis of active pulmonary TB in China and
reported a sensitivity of 89% for smear-positive patients
and a sensitivity of 74% for smear-negative patients, with
a specificity of 93%. Zhou et al. [15] have expanded the
control and patient groups and added an extrapulmonary
TB group in that they found similar results.
In our study, we evaluated the ICT Tuberculosis test to
detect IgG antibodies to five antigens (one of them was
p38) which were secreted by M. tuberculosis in patients
with TB and found that sensitivity and specificity were
33.3%, 100%, and negative predictive value was 52.9%,
respectively, for pulmonary TB.
Previous investigators reported that the sensitivity of ICT
Tuberculosis test for pulmonary TB is variable, ranging
from 20% to 73%, specificity rates were reported as 80–
100% [7,16-23]. We found a sensitivity of 33.3% for ICT
Tuberculosis test with values ranging from 39.6% to
15.8% in smear-positive and smear-negative patients,
respectively. As in previous studies, we found that sensi-
tivity of ICT Tuberculosis test is higher in smear-positive
patients than smear-negative patients, but the difference
was not statistically significant [7,14,15,17,19,22]. It is
most likely that reported higher sensitivity in smear-posi-
tive patients may be due to the higher bacillary loads and
thus a greater exposure to antigens and a more vigorous
antibody response in these patients.
Conclusion
In conclusion, ICT Tuberculosis test can be used to aid TB
diagnosis in smear-positive patients until the culture
results are available.
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